Urinary markers of kidney injury and kidney function decline in HIV-infected women

Journal of Acquired Immune Deficiency Syndromes

Volumn 61, Issue 5, 2012, Pages 565-573

  Shlipak, Michael G ^a,b   Scherzer, Rebecca ^a,b   Abraham, Alison ^c   Tien, Phyllis C ^a,b   Grunfeld, Carl ^a,b   Peralta, Carmen A ^a,b   Devarajan, Prasad ^d   Bennett, Michael ^d   Butch, Anthony W ^e   Anastos, Kathryn ^f   Cohen, Mardge H ^g   Nowicki, Marek ^h   Sharma, Anjali ⁱ   Young, Mary A ^j   Sarnak, Mark J ^k   Parikh, Chirag R ^l,m  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g RUSH UNIVERSITY   (United States)

^h UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁱ Downstate Health Sciences University   (United States)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^k TUFTS MEDICAL CENTER   (United States)

^l YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m YALE UNIVERSITY   (United States)

more..

Author keywords

Albumin to creatinine ratio; Cystatin C; HIV; IL 18; Kidney injury; KIM 1; NGAL

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 18; LOW DENSITY LIPOPROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN; LIPOCALIN; MEMBRANE PROTEIN; ONCOPROTEIN; VIRUS RECEPTOR;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE; MAJOR CLINICAL STUDY; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; YOUNG ADULT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALBUMINURIA; CASE CONTROL STUDY; DISEASE COURSE; INJURY; KIDNEY; MULTICENTER STUDY; PATHOPHYSIOLOGY; RISK FACTOR; URINE;

ACUTE-PHASE PROTEINS; ADULT; AIDS-ASSOCIATED NEPHROPATHY; ALBUMINURIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; INTERLEUKIN-18; KIDNEY; LIPOCALINS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RISK FACTORS;

EID: 84873120242     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182737706     Document Type: Article

References (43)

1. Lucas GM, Mehta SH, Atta M.G., et al End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21:2435-2443.
2. National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System. Bethesda, MD: National Institutes of Health; 2009. Available at: http://www.usrds.org. Accessed July 28, 2009.
3. Choi AI, Li Y, Deeks S.G., et al Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation. 2010;121:651-658.
4. George E, Lucas GM, Nadkarni G.N., et al Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS. 2010; 24:387-394.
5. Wyatt CM, Hoover DR, Shi Q, et al Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection. J Acquir Immune Defic Syndr. 2010;55:73-77.
6. Szczech LA, Hoover DR, Feldman J.G., et al Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39:1199-1206.
7. Wu I, Parikh CR Screening for kidney diseases: older measures versus novel biomarkers. Clin J Am Soc Nephrol. 2008;3:1895-1901.
8. Stevens LA, Coresh J, Greene T., et al Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med. 2006; 354:2473-2483.
9. Odden MC, Scherzer R, Bacchetti P., et al Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med. 2007;167:2213-2219.
10. Longenecker CT, Scherzer R, Bacchetti P., et al HIV viremia and changes in kidney function. AIDS. 2009;23:1089-1096.
11. Choi A, Scherzer R, Bacchetti P., et al Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis. 2010;56:872-882.
12. Szczech LA, Grunfeld C, Scherzer R., et al Microalbuminuria in HIV infection. AIDS. 2007;21:1003-1009.
13. Ross MJ, Klotman PE Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002;13:2997-3004.
14. Bruggeman LA, Ross MD, Tanji N, et al Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11: 2079-2087.
15. Winston JA, Bruggeman LA, Ross M.D., et al Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med. 2001;344:1979-1984.
16. Wyatt CM, Morgello S, Katz-Malamed R, et al The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 2009;75:428-434.
17. Bolignano D, Coppolino G, Campo S., et al Neutrophil gelatinase- associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373-378.
18. Barkan SE, Melnick SL, Preston-Martin S, et al The women's inter-agency HIV study. WIHS Collaborative Study Group. Epidemiology. 1998;9:117-125.
19. Bacon MC, von Wyl V, Alden C, et al The women's interagency HIV study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005;12:1013-1019.
20. Chaturvedi S, Farmer T, Kapke GF Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci. 2009;5: 128-134.
21. Bennett M, Dent CL, Ma Q, et al Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol. 2008;3:665-673.
22. Inker LA, Eckfeldt J, Levey A.S., et al Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis. 2011;58:682-684.
23. Stevens LA, Coresh J, Schmid C.H., et al Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51: 395-406.
24. Gilks WR, Richardson S, Spiegehalter DJ Markov Chain Monte Carlo in Practice. London, United Kingdom: Chapman & Hall; 1996.
25. Kenward MG. A method for comparing profiles of repeated measurements. J R Statist Soc Ser C. 1987;36:296-308.
26. Robins JM, Finkelstein DM Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000;56: 779-788.
27. Lucas GM, Lau B, Atta M.G., et al Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197:1548-1557.
28. Ando M, Yanagisawa N, Ajisawa A., et al Kidney tubular damage in the absence of glomerular defects in HIV-infected patients on highly active antiretroviral therapy. Nephrol Dial Transplant. 2011;26: 3224-3229.
29. Peralta CA, Katz R, Bonventre J.V., et al The associations of urinary Levels of Kidney Injury Molecule-1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) with Kidney Function Decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. E-pub ahead of print: 2012.
30. Bhavsar NA, Kottgen A, Coresh J., et al Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2012;60:233-240.
31. Melnikov VY, Ecder T, Fantuzzi G., et al Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001;107:1145-1152.
32. Melnikov VY, Faubel S, Siegmund B., et al Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest. 2002;110:1083-1091.
33. Bonventre JV. Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant. 2009;24:3265-3268.
34. Belcher JM, Edelstein CL, Parikh CR Clinical applications of bio-markers for acute kidney injury. Am J Kidney Dis. 2011;57:930-940.
35. Parikh CR, Lu JC, Coca S.G., et al Tubular proteinuria in acute kidney injury: a critical evaluation of current status and future promise. Ann Clin Biochem. 2010;47(pt 4):301-312.
36. Parikh CR, Devarajan P, Zappitelli M., et al Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011;22:1748-1757.
37. Paragas N, Qiu A, Zhang Q., et al The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med. 2011;17: 216-222.
38. Rifkin DE, Shlipak MG, Katz R, et al Rapid kidney function decline and mortality risk in older adults. Arch Intern Med. 2008;168:2212-2218.
39. Shlipak MG, Katz R, Kestenbaum B., et al Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20:2625-2630.
40. Matsushita K, Selvin E, Bash L.D., et al Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol. 2009;20:2617-2624.
41. Scherzer R, Estrella M, Li Y., et al Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS. 2012;26: 867-875.
42. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006;113:2335-2362.
43. Hsu CY, Propert K, Xie D., et al Measured GFR does not outperform estimated GFR in predicting CKD-related complications. J Am Soc Nephrol. 2011;22:1931-1937.